by helios » Mon Mar 15, 2021 3:08 pm
I missed out on the sage of $BLUE lentiglobin, stock rebounded on the clarification that the Lentivirus vector wasn't the causative agent ... but is the FDA convinced? the incident kinda reflected that we should look at non-viral vector approach, and I took an instinct to buy some $ZIOP upon nice presentation and backers behind them.
Added a bit more $TEVA and $AULT; will find a good time to exit all in Q2 ....
Added back $VXRT riskier trade with a view of JnJ option in by 03 May?
USA looks to get vaccination timely, and maybe the markets will respond in April - May thereof? Biopharma stocks haven't recovered much except those related to covid plays ...